FDA issues health alert saying weight loss drug could increase risk of cancer

Top Stories
FDA-building-jpg_20160229205004-159532

WHITE OAK, Maryland (VOD) A prescribed weight-loss drug may be associated with an increased risk of cancer.

That is according to an alert published by the FDA.

The agency says a clinical trial assessing Belviq’s safety showed a quote “possible increased risk of cancer.”

The alert does not specify what types of cancer were diagnosed.

However, the FDA says they cannot conclude the drug contributed to the risk, and they are still reviewing the trial’s results.

Belviq was approved in 2012.

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Right Now

Community Calendar

Don't Miss

KETK Twitter & Facebook

Trending Stories